“Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s309, https://doi.org/10.25251/skin.8.supp.309.